Skip to content

Adults with Moderate-to-Severe Plaque Psoriasis and Obesity

NO LONGER ACCEPTING APPLICATIONS
Published on:
October 4, 2024
Sign-up Expiration:
Updated:
Topics:
Locations:

The purpose of this research study is to learn more about Tirzepatide used with Ixekizumab. Tirzepatide is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems or lose weight and keep it off. Tirzepatide is being investigated in this study to see if weight loss improves plaque psoriasis. Ixekizumab may be available by prescription for treatment of autoimmune diseases, including plaque psoriasis.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials
ENDED